Table 3.
kf,rel (s−1) at pCa 4.8 | NTGβ | NTGβ,PKA | t/tβ | t/tβ,PKA | ANOVA |
---|---|---|---|---|---|
n | 9 | 8 | 10 | 10 | |
Pi (mM) = 0 | 46.96 ± 1.16 | 56.86 ± 2.74 | 63.31 ± 2.40 | 61.70 ± 1.26 | Main effects |
1 | 49.01 ± 2.06 | 62.68 ± 2.76 | 67.39 ± 2.19 | 70.74 ± 2.47 | †MYBPC3, †Pi, †PKA |
2 | 50.39 ± 2.15 | 64.55 ± 3.70 | 71.23 ± 2.38 | 77.41 ± 2.78 | |
3 | 51.50 ± 2.24 | 69.78 ± 3.73 | 78.09 ± 2.05 | 82.30 ± 2.26 | Interactions |
4 | 55.78 ± 2.40 | 74.02 ± 4.40 | 80.59 ± 2.31 | 87.29 ± 2.99 | †Pi × MYBPC3 |
5 | 60.05 ± 2.12 | 76.68 ± 3.90 | 85.63 ± 2.52 | 92.70 ± 2.64 | †Pi × PKA |
8 | 61.17 ± 2.72 | 80.35 ± 3.29 | 93.04 ± 2.41 | 99.86 ± 3.19 | |
12 | 63.60 ± 3.35 | 86.86 ± 3.25 | 96.71 ± 3.25 | 106.46 ± 3.54 | |
Δkf,rel/ΔPi | 2.15 ± 0.24 | 3.27 ± 0.48 | 4.35 ± 0.37 | 5.51 ± 0.30 | †MYBPC3, †PKA |
kf,rel (s-1) at pCa 5.75 | |||||
Pi (mM) = 0 | 50.59 ± 1.87 | 64.13 ± 3.88 | 73.30 ± 3.31 | 70.59 ± 2.45 | Main effects |
1 | 52.22 ± 1.84 | 65.87 ± 2.21 | 76.84 ± 3.33 | 72.80 ± 2.45 | †MYBPC3, †Pi, †PKA |
2 | 54.76 ± 2.41 | 66.53 ± 2.20 | 80.43 ± 3.67 | 79.32 ± 2.93 | |
3 | 57.71 ± 2.26 | 68.76 ± 2.31 | 83.87 ± 2.73 | 82.54 ± 2.60 | Interactions |
4 | 60.26 ± 2.18 | 75.74 ± 2.12 | 88.13 ± 3.46 | 84.86 ± 2.46 | †PKA × MYBPC3 |
5 | 63.81 ± 2.19 | 79.94 ± 2.70 | 89.95 ± 3.24 | 89.34 ± 2.60 | |
8 | 66.37 ± 2.35 | 85.50 ± 2.96 | 93.21 ± 3.45 | 95.84 ± 3.19 | |
12 | 69.76 ± 2.42 | 83.84 ± 3.60 | 93.66 ± 3.74 | 94.29 ± 2.19 | |
Δkf,rel/ΔPi | 2.64 ± 0.25 | 2.68 ± 0.54 | 3.45 ± 0.33 | 3.81 ± 0.37 | *MYBPC3 |
Values are means ± SE; n, number of strips. The sensitivity of kf,rel to Pi, Δkf,rel/ΔPi, was calculated as the slope of linear regression using values measured at 0–5 mM Pi. Statistical results reflect repeated-measures ANOVA. Two-way ANOVA was then used to determine whether Δkf,rel/ΔPi was influenced by absence of cMyBP-C and/or PKA. *P < 0.05, †P < 0.01. NTGβ, nontransgenic; t/tβ, transgenic lacking cMyBP-C; PKA, protein kinase A.